Search

  • Sort by

  • Category

  • Post Type

  • Reset

Plea Agreement, USA v Jeremy Brown

October 22, 2024
Posted in , ,

United States District Court Western District of Vermont USA v Jeremy Brown Plea Agreement Filed September 13, 2024 Read the document. 

Read More

Information, USA v Jeremy Brown

October 22, 2024
Posted in , ,

United States District Court Western District of Vermont USA v Jeremy Brown Information Filed September 13, 2024 Read the document. 

Read More

A DSCSA-newbies guide to the recent FDA DSCSA announcement

October 22, 2024
Posted in ,

The FDA recently announced that “connected trading partners” that have made progress in transmitting electronic data that identifies and follow medicines made for the U.S. drug supply will not be penalized if they are still working out challenges in the process. Are you wondering what that means? We can explain.

Read More
Andrea Thomas speaking at PSM's Fall 2019 Congressional Briefing

October 21, 2024: PSM advisory board member leads petition for tariffs over fentanyl precursors from China

October 21, 2024
Posted in

Family advocates petition the Office of U.S. Trade Representative to take trade action over Chinese fentanyl precursors. The New York Times tackles PBMs and pharmacy deserts.

Read More

FDA Alert: Pain Relief-Marketed Dietary Supplement Recalled For Containing Prescription Steroids, Muscle Relaxants, and OTC Pain Relievers

October 21, 2024
Posted in ,

Consumers taking this product should immediately consult with their health care professional to safely discontinue use of this product. The risks of withdrawal from corticosteroids should be assessed by a healthcare professional. Only licensed health care professionals can evaluate patients for the risk, or confirm the existence, of adrenal suppression. Consumers that have product which is being recalled should return to place of purchase or discard.

Read More

October 15, 2024: FDA issues new DSCSA guidance

October 16, 2024
Posted in

The FDA granted exemptions for certain trading partners and small dispensers to avoid supply chain disruptions. Stories from the week in counterfeit medicine news.

Read More

PSM Advocates for SHOP SAFE legislation at Anti-Counterfeiting Day on the Hill

October 8, 2024
Posted in ,

Our Executive Director, Shabbir Safdar, along with PSM members, shared examples of pharmaceutical counterfeits and helped attendees understand why current systems for stopping counterfeit product sales do not work well.

Read More

October 7, 2024: DEA warning – Dozens of fake online pharmacies sold millions of fake pills to customers in all 50 states

October 7, 2024
Posted in ,

An indictment by the Department of Justice against 18 individuals who allegedly sold counterfeit pills via dozens of fake pharmacy websites to residents in all 50 states prompts warnings from two additional federal agencies.

Read More

What it means that the shortage of weight loss drugs is almost over

October 3, 2024
Posted in

Drug shortages attract patient risk in many forms. Since first seeing compounded semaglutide for sale on Etsy in early 2023, the Partnership for Safe Medicines has recognized the unique threats that counterfeit and substandard versions of FDA-approved diabetes and obesity injectable medicines pose to consumer safety. Because unprecedented demand has outweighed the FDA-approved supply, PSM has used its platform as…

Read More

September 30, 2024: 27 individuals indicted in Puerto Rico over wholesale distribution of misbranded and diverted medicine

September 30, 2024
Posted in ,

Twenty-seven people in Puerto Rico indicted in misbranded and diverted drug case, CBP seized counterfeit and misbranded drugs in two states, and fake arthritis and cancer medications seized in India.

Read More